Endo ERN
Find an expert
Endo ERN
Search
  • Rare Endocrine Conditions

    Endocrine Conditions

    Endo-ERN is focused on 8 main thematic groups (MTGs) which cover rare and/or complex endocrine conditions

    Go to overview

    Categories

    • MTG1Adrenal
    • MTG2Disorders of Calcium & Phosphate Homeostasis
    • MTG3Genetic Disorders of Glucose & Insulin Homeostasis
    • MTG4Genetic Endocrine Tumour Syndromes
    • MTG5Growth & Genetic Obesity Syndromes
    • MTG6Hypothalamic and Pituitary Conditions
    • MTG7Sex Development & Maturation
    • MTG8Thyroid
  • About Us

    About Us

    Endo-ERN is a network of 100+ Reference Centres (RCs) in 27 EU member states+Norway that offers access to clinical experts for patients with rare endocrine conditions.  

    Go to overview

    Who we are

    • About Endo-ERN
    • What we do
    • Reference centres
    • Work packages
    • Project team

    Information

    • Events
    • FAQ
    • Newsletter
    • Contact
    • ERNs
  • For Professionals

    For Professionals

    Endo-ERN is the network for rare endocrine conditions providing healthcare professionals with access to a variety of resources to support patient care.  

    Our Network

    • About Endo-ERN
    • Find a Reference Centre

    Research

    • Registries
    • Publications
    • Clinical Trials

    Support Tools

    • Virtual Consultations
    • Guidelines
    • COVID-19

    Training & Education

    • Webinars
    • Exchange Programme
  • For Members

    For Members

    If you work at a member institution this page will help with your Endo-ERN contributions.  

    Go to overview

    Quick Links

    • Cite Endo-ERN
    • CPMS 2.0
    • GA2026
    • The Journal

    Evaluation

    • Continuous Monitoring Exercise
    • 5-year evaluation
    • HCP Performance System

    Network Participation

    • Event Endorsement
    • Member Survey
    • Webinar Planning
    • MTG Representatives

    Membership Management

    • Update Member Contacts
    • Request Disease Area Expansion
    • Termination Policy
  • For Patients

    For Patients

    Access to rare disease expertise without the need to travel is a core ERN objective.  Our ePAGs contribute to all Endo-ERN activities.  

    Go to overview

    Patient information

    • What are European Reference Networks?
    • Cross-border healthcare
    • Rare endocrine conditions
    • Patient materials

    ePAG information

    • European Patient Advocacy Groups
    • Patient representatives
    • How to become an Endo-ERN ePAG
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
Endo ERN
Find an expert
Search
/ Publications Overview / Publications Database

Endo-ERN Publications Database

RDD IssuesBack to Publications Overview

Filter list of publications

890 publication(s) found matching the search criteria

Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers


Author(s): Giustina A, Uygur MM, Frara S, Barkan A, Biermasz NR, Chanson P, Freda P, Gadelha M, Kaiser UB, Lamberts S, Laws E, Nachtigall LB, Popovic V, Reincke M, Strasburger C, van der Lely AJ, Wass JAH, Melmed S, Casanueva FF
Affiliated Institution / ERN: Charité Universitätsmedizin Berlin ;
Condition / Disease: Pituitary adenoma
Publication: Pituitary v26.5 p583-596 Year: 2023 ORPHAcode / other: ORPHA99408
DOI: 10.1007/s11102-023-01345-0 Keywords: Acromegaly,Centers of Excellence,Criteria,Cushing’s disease,Medical treatment,Neurosurgery,Pituitary tumors,Prolactinoma
MTG6

Giant prolactinomas, a detailed analysis of 196 adult cases


Author(s): Lisa B, Arno V, Christophe DB, Heyning Paul Vd, Carlien DH
Affiliated Institution / ERN: UZ Antwerpen ;
Condition / Disease: Prolactinoma
Publication: Pituitary v26.5 p529-537 Year: 2023 ORPHAcode / other: ORPHA2965
DOI: 10.1007/s11102-023-01337-0 Keywords: Dopamine agonists,Giant prolactinoma,Hyperprolactinemia,Prolactin,Prolactinoma
MTG6

Characterisation and clinical outcomes in children and adolescents with diabetes according to newly defined subgroups: a cohort study from the DPV registry


Author(s): Warncke K, Eckert A, Bonifacio E, Achenbach P, Kordonouri O, Meissner T, Ohlenschläger U, Bonfig W, Ziegler A, Holl RW
Affiliated Institution / ERN: Klinikum Wels Grieskirchen ;
Condition / Disease: diabetes type 1
Publication: eClinicalMedicine v64 p102208 Year: 2023 ORPHAcode / other:
DOI: 10.1016/j.eclinm.2023.102208 Keywords: Children,Complications,Diabetes,Personalised medicine,Subgroups
MTG3

Recent data on iodine intake in Croatian schoolchildren: results of 2014–2019 survey


Author(s): Filipan D, Vidranski V, Bosak Butković M, Blažeković I, Romić M, Mihaljević I, Bogović Crnčić T, Kusić Z, Šamija I, Fröbe A, Jukić T
Affiliated Institution / ERN: Sestre milosrdnice University Hospital Center ;
Condition / Disease: Thyroid volume iodine intake hypothyroidism
Publication: European Journal of Clinical Nutrition v77.10 p959-965 Year: 2023 ORPHAcode / other:
DOI: 10.1038/s41430-023-01301-y Keywords:
MTG8

Testosterone Restores Body Composition, Bone Mass, and Bone Strength Following Early Puberty Suppression in a Mouse Model Mimicking the Clinical Strategy in Trans Boys


Author(s): Dubois V, Ciancia S, Doms S, El Kharraz S, Sommers V, Kim NR, David K, Van Dijck J, Valle-Tenney R, Maes C, Antonio L, Decallonne B, Carmeliet G, Claessens F, Cools M, Vanderschueren D
Affiliated Institution / ERN: UZ Leuven ;
Condition / Disease: Gender dysphoria
Publication: Journal of Bone and Mineral Research v38.10 p1497-1508 Year: 2023 ORPHAcode / other: HA61
DOI: 10.1002/jbmr.4832 Keywords: BODY COMPOSITION,BONE,GNRHA,MOUSE MODEL,TESTOSTERONE,TRANSGENDER
MTG7

Endocortical Trabecularization in Acromegaly: The Cause for the Paradoxically Increased Vertebral Fracture Risk?


Author(s): Heck A, Godang K, Lekva T, Markussen KN, De Vincentis S, Ueland T, Bollerslev J
Affiliated Institution / ERN: AOU - Modena ; Oslo University Hospital ;
Condition / Disease: Acromegaly
Publication: JBMR Plus v7.10 Year: 2023 ORPHAcode / other: ORPHA963
DOI: 10.1002/jbm4.10787 Keywords: DXA,TBS,hip structural analysis,remodeling,trabecular separation
MTG6

Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study


Author(s): Terzolo M, Fassnacht M, Perotti P, Libé R, Kastelan D, Lacroix A, Arlt W, Haak HR, Loli P, Decoudier B, Lasolle H, Quinkler M, Haissaguerre M, Chabre O, Caron P, Stigliano A, Giordano R, Zatelli MC, Bancos I, Fragoso MCBV, Canu L, Luconi M, Puglisi S, Basile V, Reimondo G, Kroiss M, Megerle F, Hahner S, Kimpel O, Dusek T, Nölting S, Bourdeau I, Chortis V, Ettaieb MH, Cosentini D, Grisanti S, Baudin E, Berchialla P, Bovis F, Sormani MP, Bruzzi P, Beuschlein F, Bertherat J, Berruti A
Affiliated Institution / ERN: AO City of Health and Science - Turin ;
Condition / Disease: Adrenocortical carcinomas
Publication: The Lancet Diabetes & Endocrinology v11.10 p720-730 Year: 2023 ORPHAcode / other: ORPHA1501
DOI: 10.1016/s2213-8587(23)00193-6 Keywords:
MTG1

Unravelling leptin variants: advancing precision medicine in obesity


Author(s): Dubern B, Clément K
Affiliated Institution / ERN: Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpétrière ;
Condition / Disease: obesity associated with defect in leptin/melanocortin pathway
Publication: Nature Reviews Endocrinology v19.10 p562-563 Year: 2023 ORPHAcode / other: ORPHA77828
DOI: 10.1038/s41574-023-00882-9 Keywords:
MTG5

Predictors of surgical complications in boys with hypospadias: data from an international registry


Author(s): Scougall K, Bryce J, Baronio F, Boal RL, Castera JR, Castro S, Cheetham T, Costa EC, Darendeliler F, Davies JH, Dirlewanger M, Gazdagh G, Globa E, Guerra-Junior G, Guran T, Herrmann G, Holterhus P, Akgül AK, Markosyan R, McElreavey K, Miranda ML, Nordenstrom A, O’Toole S, Poyrazoglu S, Russo G, Schwitzgebel V, Stancampiano M, Steigert M, Ahmed SF, Lucas-Herald AK
Affiliated Institution / ERN: AOU-Bologna ;
Condition / Disease: Hypospadias
Publication: World Journal of Pediatric Surgery v6.4 pe000599 Year: 2023 ORPHAcode / other: ORPHA95706
DOI: 10.1136/wjps-2023-000599 Keywords: Endocrinology,Pediatrics
MTG7

Magnetic resonance imaging as a predictor of therapeutic response to pasireotide in acromegaly


Author(s): Ruiz S, Gil J, Biagetti B, Venegas E, Cámara R, Garcia‐Centeno R, Gálvez M, Picó A, Maraver S, González I, Abellán P, Trincado P, Herrera M, Olvera P, Xifra G, Bernabeu I, Serra‐Soler G, Azriel S, García L, Carvalho D, Jordà M, Valassi E, Puig J, Puig‐Domingo M
Affiliated Institution / ERN: Hospital Universitari Vall d’Hebron ; São João University Hospital(CHUSJ) ;
Condition / Disease: Acromegaly
Publication: Clinical Endocrinology v99.4 p378-385 Year: 2023 ORPHAcode / other: ORPHA963; ORPHA314769
DOI: 10.1111/cen.14946 Keywords: IGF-1,T2-weighted signal intensity,acromegaly,magnetic resonance imaging,pasireotide,somatostatin receptor ligands
MTG6

Giant prolactinomas, a detailed analysis of 196 adult cases


Author(s): Billion L, Verleye A, Block CD, Heyning PVd, Herdt CD
Affiliated Institution / ERN: UZ Antwerpen ;
Condition / Disease: Prolactinoma
Publication: Pituitary v26.5 p529-537 Year: 2023 ORPHAcode / other: ORPHA2965
DOI: 10.1007/s11102-023-01337-0 Keywords: Dopamine agonists,Giant prolactinoma,Hyperprolactinemia,Prolactin,Prolactinoma
MTG6

Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study


Author(s): Terzolo M, Fassnacht M, Perotti P, Libé R, Kastelan D, Lacroix A, Arlt W, Haak HR, Loli P, Decoudier B, Lasolle H, Quinkler M, Haissaguerre M, Chabre O, Caron P, Stigliano A, Giordano R, Zatelli MC, Bancos I, Fragoso MCBV, Canu L, Luconi M, Puglisi S, Basile V, Reimondo G, Kroiss M, Megerle F, Hahner S, Kimpel O, Dusek T, Nölting S, Bourdeau I, Chortis V, Ettaieb MH, Cosentini D, Grisanti S, Baudin E, Berchialla P, Bovis F, Sormani MP, Bruzzi P, Beuschlein F, Bertherat J, Berruti A
Affiliated Institution / ERN: AOU - Ferrara ; University Hospital Würzburg ; Assistance Publique-Hôpitaux de Paris, Hôpital Cochin ; Maastricht University Medical Center+ ; Hospices Civils de Lyon ;
Condition / Disease: Adrenocortical carcinoma
Publication: The Lancet Diabetes & Endocrinology v11.10 p720-730 Year: 2023 ORPHAcode / other: ORPHA1501
DOI: 10.1016/S2213-8587(23)00193-6 Keywords:
MTG1

Subcentimetric papillary thyroid carcinoma with extensive lymph node and brain metastasis: case report and review of literature


Author(s): Amado A, Teixeira E, Canberk S, Macedo S, Castro B, Pereira H, Varanda J, Graça S, Tavares A, Soares C, Oliveira MJ, Oliveira M, Soares P, Sobrinho Simões M, Póvoa AA
Affiliated Institution / ERN: São João University Hospital(CHUSJ) ;
Condition / Disease: papillary thyroid carcinoma
Publication: Endocrinology, Diabetes & Metabolism Case Reports v2023.4 Year: 2023 ORPHAcode / other: ORPHA146
DOI: 10.1530/edm-23-0025 Keywords:
MTG8

The effect of testosterone treatment on bone mineral density in Klinefelter syndrome: A retrospective cohort study


Author(s): Willems S, David K, Decallonne B, Marcq P, Antonio L, Vanderschueren D
Affiliated Institution / ERN:
Condition / Disease: Klinefelter syndrome
Publication: Andrology v11.7 p1295-1302 Year: 2023 ORPHAcode / other: ORPHA484
DOI: 10.1111/andr.13411 Keywords: Klinefelter syndrome,bone mineral density,dual-energy X-ray absorptiometry,hypogonadism,testosterone replacement therapy
MTG7

Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine


Author(s): Tobias DK, Merino J, Ahmad A, Aiken C, Benham JL, Bodhini D, Clark AL, Colclough K, Corcoy R, Cromer SJ, Duan D, Felton JL, Francis EC, Gillard P, Gingras V, Gaillard R, Haider E, Hughes A, Ikle JM, Jacobsen LM, Kahkoska AR, Kettunen JLT, Kreienkamp RJ, Lim L, Männistö JME, Massey R, Mclennan N, Miller RG, Morieri ML, Most J, Naylor RN, Ozkan B, Patel KA, Pilla SJ, Prystupa K, Raghavan S, Rooney MR, Schön M, Semnani-Azad Z, Sevilla-Gonzalez M, Svalastoga P, Takele WW, Tam CH, Thuesen ACB, Tosur M, Wallace AS, Wang CC, Wong JJ, Yamamoto JM, Young K, Amouyal C, Andersen MK, Bonham MP, Chen M, Cheng F, Chikowore T, Chivers SC, Clemmensen C, Dabelea D, Dawed AY, Deutsch AJ, Dickens LT, DiMeglio LA, Dudenhöffer-Pfeifer M, Evans-Molina C, Fernández-Balsells MM, Fitipaldi H, Fitzpatrick SL, Gitelman SE, Goodarzi MO, Grieger JA, Guasch-Ferré M, Habibi N, Hansen T, Huang C, Harris-Kawano A, Ismail HM, Hoag B, Johnson RK, Jones AG, Koivula RW, Leong A, Leung GKW, Libman IM, Liu K, Long SA, Lowe WL, Morton RW, Motala AA, Onengut-Gumuscu S, Pankow JS, Pathirana M, Pazmino S, Perez D, Petrie JR, Powe CE, Quinteros A, Jain R, Ray D, Ried-Larsen M, Saeed Z, Santhakumar V, Kanbour S, Sarkar S, Monaco GSF, Scholtens DM, Selvin E, Sheu WH, Speake C, Stanislawski MA, Steenackers N, Steck AK, Stefan N, Støy J, Taylor R, Tye SC, Ukke GG, Urazbayeva M, Van der Schueren B, Vatier C, Wentworth JM, Hannah W, White SL, Yu G, Zhang Y, Zhou SJ, Beltrand J, Polak M, Aukrust I, de Franco E, Flanagan SE, Maloney KA, McGovern A, Molnes J, Nakabuye M, Njølstad PR, Pomares-Millan H, Provenzano M, Saint-Martin C, Zhang C, Zhu Y, Auh S, de Souza R, Fawcett AJ, Gruber C, Mekonnen EG, Mixter E, Sherifali D, Eckel RH, Nolan JJ, Philipson LH, Brown RJ, Billings LK, Boyle K, Costacou T, Dennis JM, Florez JC, Gloyn AL, Gomez MF, Gottlieb PA, Greeley SAW, Griffin K, Hattersley AT, Hirsch IB, Hivert M, Hood KK, Josefson JL, Kwak SH, Laffel LM, Lim SS, Loos RJF, Ma RCW, Mathieu C, Mathioudakis N, Meigs JB, Misra S, Mohan V, Murphy R, Oram R, Owen KR, Ozanne SE, Pearson ER, Perng W, Pollin TI, Pop-Busui R, Pratley RE, Redman LM, Redondo MJ, Reynolds RM, Semple RK, Sherr JL, Sims EK, Sweeting A, Tuomi T, Udler MS, Vesco KK, Vilsbøll T, Wagner R, Rich SS, Franks PW
Affiliated Institution / ERN: Aarhus University Hospital ;
Condition / Disease: Precision diabetes medicine
Publication: Nature Medicine v29.10 p2438-2457 Year: 2023 ORPHAcode / other: ORPHA552
DOI: 10.1038/s41591-023-02502-5 Keywords:
MTG3

Treatment and long-term outcome in primary nephrogenic diabetes insipidus


Author(s): Lopez-Garcia SC, Downie ML, Kim JS, Boyer O, Walsh SB, Nijenhuis T, Papizh S, Yadav P, Reynolds BC, Decramer S, Besouw M, Perelló Carrascosa M, La Scola C, Trepiccione F, Ariceta G, Hummel A, Dossier C, Sayer JA, Konrad M, Keijzer-Veen MG, Awan A, Basu B, Chauveau D, Madariaga L, Koster-Kamphuis L, Furlano M, Zacchia M, Marzuillo P, Tse Y, Dursun I, Pinarbasi AS, Tramma D, Hoorn EJ, Gokce I, Nicholls K, Eid LA, Sartz L, Riordan M, Hooman N, Printza N, Bonny O, Arango Sancho P, Schild R, Sinha R, Guarino S, Martinez Jimenez V, Rodríguez Peña L, Belge H, Devuyst O, Wlodkowski T, Emma F, Levtchenko E, Knoers NVAM, Bichet DG, Schaefer F, Kleta R, Wasilewska A, Longo G, Espinosa L, Miglinas M, Stroescu R, Huseynova S, Stabouli S, Sathyanarayana V, Andronesi AG, Hahn D, Sharma D, Petrosyan E, Frangou E, Mohebbi N, Dinçel NT, Braconnier P, Gilbert RD, Sambo A, Tasic V, Henne T, Bockenhauer D
Affiliated Institution / ERN:
Condition / Disease:
Publication: Nephrology Dialysis Transplantation v38.10 p2120-2130 Year: 2023 ORPHAcode / other:
DOI: 10.1093/ndt/gfaa243 Keywords: AQP2,AVPR2,chronic kidney disease,flow uropathy,nephrogenic diabetes insipidus

The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data


Author(s): Ariceta G, Beck-Nielsen SS, Boot AM, Brandi ML, Briot K, de Lucas Collantes C, Emma F, Giannini S, Haffner D, Keen R, Levtchenko E, Mӓkitie O, Mughal MZ, Nilsson O, Schnabel D, Tripto-Shkolnik L, Liu J, Williams A, Wood S, Zillikens MC
Affiliated Institution / ERN: Erasmus MC: University Medical Center Rotterdam ;
Condition / Disease: XLH
Publication: Orphanet Journal of Rare Diseases v18.1 Year: 2023 ORPHAcode / other: ORPHA89936
DOI: 10.1186/s13023-023-02882-4 Keywords: Fibroblast growth factor 23 (FGF23),Hypophosphatemic rickets,International,Natural history,Osteomalacia,PHEX mutation,Patient registry,Rare disease,X-linked hypophosphatemia (XLH)
MTG2

First results of the growth disorders related twinning programme Partners4Growth implemented at the tertiary university pediatric endocrinology clinics in Bulgaria


Author(s): Elkina SM, Halvadzhiyan IB, Popova GT, Avdjieva-Tzavella DM, Stefanova E, Kaleva NN, Stoeva IH, Petrova CK, Iotova VM
Affiliated Institution / ERN: USHATE “ACAD IVAN Penchev” ;
Condition / Disease: Growth disorders
Publication: Journal of Pediatric Endocrinology and Metabolism v36.9 p832-841 Year: 2023 ORPHAcode / other: ORPHA631; ORPHA101957
DOI: 10.1515/jpem-2022-0584 Keywords: GH treatment,diagnosis,growth disorders,twinning programme
MTG5 MTG6

SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood


Author(s): Lugar M, Eugster A, Achenbach P, von dem Berge T, Berner R, Besser REJ, Casteels K, Elding Larsson H, Gemulla G, Kordonouri O, Lindner A, Lundgren M, Müller D, Oltarzewski M, Rochtus A, Scholz M, Szypowska A, Todd JA, Ziegler A, Bonifacio E, Gündert M, Haupt F, Arnolds S, Blasius K, Friedl N, Gezginci C, Göppel G, Heigermoser M, Hergl M, Höfelschweiger B, Jolink M, Kisfügedi K, Klein N, Matzke C, Niewöhner R, Schütte-Borkovec K, Weiß A, Zapardiel Gonzalo JM, Schmidt S, Vurucu M, Sarcletti K, Sporreiter M, Jacobson S, Janssen C, Morobé H, Vrancken B, Van den Driessche N, Van Poel G, Van Heyste R, Houben J, Vanhuyse V, Arabi S, Barbknecht L, Dietz S, Ehrlich F, Gholizadeh Z, Hoffmann R, Hommel A, Lange F, Loff A, Morgenstern R, Schille A, Sigg M, Weigelt M, Weise A, Zubizarreta  N, Danne T, Galuschka L, Kruse C, Landsberg S, Lange K, Marquardt E, Reschke F, Roloff F, Weiskorn J, Polier M, Schmidt B, Bunk M, Hofelich A, Huber E, Kaiser M, Käßl A, Marcus B, Munzinger A, Ramminger C, Reinmüller F, Vollmuth V, Winkler C, Dybkowska S, Groele L, Owczarek D, Popko K, Cieloch A, Dzygalo K, Górska E, Mroczek A, Zduńczyk B, Zych A, Czerwińska W, Dziedzic N, Samuelsson H, Alström Mortin S, Bennet R, Brundin C, Dahlberg S, Fransson L, Jönsson I, Nenonen H, Ramelius A, Törn C, Ulvenhag U, Lindström M, Rhamati K, Goldman Tsubarah M, Salami  F, Hawkins S, Mujadidi YF, Smith I, Roseman F, Robinson H, Taj N, Whelan C, Wishlade T, Vernon S, Ratcliffe H
Affiliated Institution / ERN: Public Pediatric Teaching Hospital ;
Condition / Disease: Diabetes mellitus type 1
Publication: JAMA v330.12 p1151 Year: 2023 ORPHAcode / other: ORPHA181371
DOI: 10.1001/jama.2023.16348 Keywords:
MTG3

Secondary diabetes mellitus in pheochromocytomas and paragangliomas


Author(s): Moustaki M, Paschou SA, Vakali E, Xekouki P, Ntali G, Kassi E, Peppa M, Psaltopoulou T, Tzanela M, Vryonidou A
Affiliated Institution / ERN: General Hospital of Athens “LAIKO” ;
Condition / Disease: Sporadic phaeochromocytoma/secreting paraganglioma
Publication: Endocrine v82.3 p467-479 Year: 2023 ORPHAcode / other: ORPHA276621
DOI: 10.1007/s12020-023-03492-7 Keywords: Adrenergic phenotype,Aerobic glycolysis,Impaired insulin secretion,Noradrenergic phenotype,PPGLs,Secondary diabetes mellitus
MTG1

Weekly Somapacitan in GH Deficiency: 4-Year Efficacy, Safety, and Treatment/Disease Burden Results From REAL 3


Author(s): Sävendahl L, Battelino T, Højby Rasmussen M, Brod M, Röhrich S, Saenger P, Horikawa R
Affiliated Institution / ERN: University Medical Centre Ljubljana ;
Condition / Disease: growth hormone deficiency (GHD)
Publication: The Journal of Clinical Endocrinology & Metabolism v108.10 p2569-2578 Year: 2023 ORPHAcode / other: ORPHA101957; ORPHA95488
DOI: 10.1210/clinem/dgad183 Keywords: childhood growth hormone deficiency,daily growth hormone,growth hormone treatment,long-acting growth hormone,somapacitan
MTG5 MTG6

Psychopathology in Acromegaly—Real and Perceived


Author(s): Pivonello R, Neggers SJCMM, Imran SA
Affiliated Institution / ERN: AOU Federico II - Naples ;
Condition / Disease: acromegaly
Publication: The Journal of Clinical Endocrinology & Metabolism v108.10 p2470-2474 Year: 2023 ORPHAcode / other: ORPHA963
DOI: 10.1210/clinem/dgad237 Keywords: acromegaly,anxiety,body image,depression,psychopathology,sexual function
MTG6

Adrenal function in relation to cytokines and outcome in non-critically ill patients with COVID-19


Author(s): Athanasiou N, Diamantopoulos A, Keskinidou C, Katsaounou P, Angelousi A, Jahaj E, Mourelatos P, Vrettou CS, Botoula E, Vassiliou AG, Kotanidou A, Tsagarakis S, Dimopoulou I, Vassiliadi DA
Affiliated Institution / ERN: Evangelismos General Hospital ;
Condition / Disease: adrenal function in COVID-19
Publication: Journal of Endocrinological Investigation v47.3 p721-728 Year: 2023 ORPHAcode / other:
DOI: 10.1007/s40618-023-02189-y Keywords: Adrenal,COVID-19,Cortisol,GILZ, GCR-α,IL-6,SARS-CoV-2
MTG1

Acquired hypothalamic dysfunction in childhood: ‘what do patients need?’ – an Endo-ERN survey


Author(s): van Roessel IMAA, de Graaf JP, Biermasz NR, Charmandari E, van Santen HM
Affiliated Institution / ERN: Leiden University Medical Center ; University Medical Center Utrecht ;
Condition / Disease: Acquired hypothalamic dysfunction; craniopharyngeoma; hypothalamic obesity;
Publication: Endocrine Connections Volume 12: Issue 10 Year: 2023 ORPHAcode / other: ORPHA95502; ORPHA95502; ORPHA54595
DOI: 10.1530/ec-23-0147 Keywords:
MTG6

Prolactin and Growth Hormone Signaling and Interlink Focused on the Mammosomatotroph Paradigm: A Comprehensive Review of the Literature


Author(s): Araujo-Castro M, Marazuela M, Puig-Domingo M, Biagetti B
Affiliated Institution / ERN: Hospital Universitari Vall d’Hebron ;
Condition / Disease: lactotroph and somatotroph PitNETs
Publication: International Journal of Molecular Sciences v24.18 p14002 Year: 2023 ORPHAcode / other: ORPHA99408
DOI: 10.3390/ijms241814002 Keywords: acromegaly,dopamine receptor,growth hormone,mammosomatotroph,pituitary neuroendocrine tumors,plurihormonal tumors,prolactin,prolactin receptor,somatostatin receptor
MTG6

A comment from SIGIS, SIE and SIAMS: “Puberty blockers in transgender adolescents—a matter of growing evidence and not of ideology”


Author(s): Ristori J, Motta G, Meriggiola MC, Bettocchi C, Crespi C, Falcone M, Lombardo F, Maggi M, Morelli G, Colao AM, Isidori AM, Fisher AD
Affiliated Institution / ERN: AOU Federico II - Naples ; AOU Policlinico Umberto I - Rome ; University Hospital Florence ;
Condition / Disease: Transgender, female to male
Publication: Journal of Endocrinological Investigation v47.2 p479-481 Year: 2023 ORPHAcode / other: ICD-10 F64
DOI: 10.1007/s40618-023-02173-6 Keywords:
MTG7

Pasireotide effects on biochemical control and glycometabolic profile in acromegaly patients switched from combination therapies or unconventional dosages of somatostatin analogs


Author(s): Corica G, Pirchio R, Milioto A, Nista F, Arecco A, Mattioli L, Auriemma RS, Cocchiara F, Pivonello R, Colao A, Ferone D, Gatto F
Affiliated Institution / ERN: AOU Federico II - Naples ; IRCCS Ospedale Policlinico San Martino – Genova ;
Condition / Disease: Acromegaly
Publication: Journal of Endocrinological Investigation v47.3 p683-697 Year: 2023 ORPHAcode / other: ORPHA963
DOI: 10.1007/s40618-023-02186-1 Keywords: Acromegaly,Combination,Compliance,Glucose metabolism,Pasireotide,Pegvisomant
MTG6

Whole genome sequencing resolves 10 years diagnostic odyssey in familiar myxoma


Author(s): Pálla S, Tőke J, Bozsik A, Butz H, Papp J, Likó I, Kuroli E, Bánvölgyi A, Hamar M, Bertherat J, Medvecz M, Patócs A
Affiliated Institution / ERN: Semmelweis University ;
Condition / Disease: Carney complex
Publication: Scientific Reports v13.1 Year: 2023 ORPHAcode / other: ORPHA1359
DOI: 10.1038/s41598-023-41878-9 Keywords:
MTG4

A Comparison of Faster Insulin Aspart with Standard Insulin Aspart Using Hybrid Automated Insulin Delivery System in Active Children and Adolescents with Type 1 Diabetes: A Randomized Double-Blind Crossover Trial


Author(s): Dovc K, Bergford S, Fröhlich-Reiterer E, Zaharieva DP, Potocnik N, Müller A, Lenarcic Z, Calhoun P, Fritsch M, Sourij H, Bratina N, Kollman C, Battelino T
Affiliated Institution / ERN: University Medical Centre Ljubljana ;
Condition / Disease: diabetes type 1
Publication: Diabetes Technology & Therapeutics v25.9 p612-621 Year: 2023 ORPHAcode / other:
DOI: 10.1089/dia.2023.0178 Keywords: Adolescents,Automated insulin delivery,Children,Exercise,Faster acting insulin,Type 1 diabetes
MTG3

European experience with the Afirma Gene Expression Classifier for indeterminate thyroid nodules: A clinical utility study in the Netherlands


Author(s): Lončar I, van Velsen EFS, Massolt ET, van Kemenade FJ, van Engen‐van Grunsven ACH, van Hemel BM, van Nederveen FH, Netea‐Maier R, Links TP, Peeters RP, van Ginhoven TM
Affiliated Institution / ERN: Radboud University Medical Centre Nijmegen ; University Medical Center Groningen ;
Condition / Disease: Follicular thyroid carcinoma
Publication: Head & Neck v45.9 p2227-2236 Year: 2023 ORPHAcode / other: ORPHA146
DOI: 10.1002/hed.27472 Keywords: fine-needle aspiration,gene expression classifier,genomic sequencing classifier,indeterminate thyroid nodule
MTG8
Page 7 of 30« First«...56789...2030...»Last »

Endo-ERN Newsletter

Subscribe to our newsletter to receive updates on all network activities and new resources. As soon as you subscribe you will receive an email asking you to confirm your registration.

SIGN UP NOW

News

  • All news
  • Newsletter signup

Events

  • Upcoming events
  • Webinars

Information

  • About Us
  • Contact
  • FAQs

Social Links

Linkedin Facebook Youtube

Contact

Endo-ERN
Coordinating Center
Meibergdreef 9
1105 AZ AMSTERDAM
The Netherlands

info@endo-ern.eu
Funded by the European Union
©2025. All Rights Reserved. Endo-ERN

Privacy Policy – GDPR

Website design by Elan Creative

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Information video for patients and healthcare professionals

Type and Press “enter” to Search

Search
Privacy Overview
Endo-ERN

Endo-ERN Privacy Policy

Endo-ERN is committed to user’s privacy and does not track personal data when visiting our website. We act in accordance with Regulation 2016/679 of the European Parliament and of the Council.

‘Personal data’ means any information relating to an identified or identifiable natural person. An identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as:

  • a name
  • an identification number
  • location data
  • an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person

Cookies

Endo-ERN only tracks anonymised data for statistical purposes. We do this via analytical cookies, placed through an anonymous IP Google analytics tag. The purpose of these cookies are to track the efficiency and success of the website.

These cookies do not store any personal data that can be linked to a natural person, but may save data such as inter alia, data about the website from which a person has come (the so-called referrer), which sub-pages were visited, or how often and for what duration a sub-page was viewed. The data collected through this is general data only, and cannot be traced back to one person.

It is possible to prevent the setting of cookies, by means of a setting of the Internet browser used. On top of that, already set cookies may be deleted at any time via an Internet browser or other software programs. This is possible in all popular Internet browsers.

Google Analytics does not share any data with third parties.

The principles of data protection do not apply to anonymous information and because these cookies minimally impact the privacy of the user, it is not necessary to ask for permission to use these cookies.

Newsletter

You may always unsubscribe from our newsletter at any time through the unsubscribe button located in our newsletter. Endo-ERN is both the controller and responsible for processing of any data regarding the newsletter. Endo-ERN does not make use of a third party for the Newsletter service.

E-services

Endo-ERN has a contact form, which activates your email software and allows you to send a comment or question to a general email address. When you send such a message, your personal data is collected only to the extent necessary to reply. If the team responsible for the mailbox is unable to answer your question, or your questions has regards to another party, it might forward your email to another service.

If you have any questions about the processing of your email and related personal data, do not hesitate to include them in your message.

The collected personal data and all information related to the above mentioned consultation is stored on the email server of the Endo-ERN Coordinating office and potentially those who have been concerned in the correspondence in order to respond to your comment.

Newsletter Tracking

The Endo-ERN newsletter makes use of tracking in order to be able to conduct a statistical analysis of the success or failure of online marketing campaigns. Endo-ERN may see if an email containing a newsletter was opened by a user, when it was opened, and which links were opened. 
The data collected through this tracking is generated and stored by Endo-ERN and is not shared with third parties, but may be used to adapt future content of newsletters in order to better meet the interests of our subscribers.

Contact details

For any questions regarding our privacy policy, please contact the Endo-ERN coordinating office.

You have the right to be forgotten and removed completely from the Endo-ERN contact database. To request this, please contact the Endo-ERN coordinating office.

Endo-ERN Coordinating Center, Meibergdreef 9, 1105 AZ  AMSTERDAM. The Netherlands

 info@endo-ern.eu
Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Powered by  GDPR Cookie Compliance